Efficacy of hydrate sodium calcium aluminosilicate and yeast cell wall to ameliorate the toxic effects of aflatoxin in ducks

2017 ◽  
Vol 57 (8) ◽  
pp. 1637 ◽  
Author(s):  
S. Tanpong ◽  
S. Wongtangtintharn ◽  
K. Pimpukdee ◽  
B. Tengjaroenkul ◽  
J. Khajarern

The aim of the present experiment was to evaluate the efficacy of a hydrate sodium calcium aluminosilicate and yeast cell wall (Fixar® Viva Dry) to prevent aflatoxin toxicity in meat-type ducks. In total, 336 1-day-old Cherry Valley ducks were randomly assigned to seven dietary groups, including of three diets without adsorbent. These included <30 (control), 60 and 120 μg/kg of aflatoxin in the diet and 60 or 120 μg/kg of aflatoxin supplemented with Fixar® Viva Dry at either 0.05% or 0.10% in the diet. Each treatment group was duplicated, with 24 birds per pen (replicate) throughout the 28-day trial period. The results showed that, bodyweight gain was reduced by 11% and mortality was increased by 10% in ducks fed diet containing aflatoxin at 120 μg/kg, compared with the control diet. However, dietary Fixar® Viva Dry supplementation effectively alleviated the overall toxicity induced by aflatoxin. Significant negative treatment-related changes were observed in feather growth, eye necrosis, web-toe haemorrhage, leg deformity, tibia bone porosity, liver paleness and fat content, organ weight and serum biochemical characteristics, as well as decreased leaked enzymes in blood serum, compared with the control. Addition of Fixar® Viva Dry in the diet significantly (P < 0.05) reduced the adverse effects of aflatoxin on all parameters measured, near to those in the control group. This finding indicated that Fixar® Viva Dry, when added at the level of 0.05% in 60 μg/kg or of 0.10% in 120 μg/kg aflatoxin diets, could modulate the toxicity of aflatoxin. In conclusion, these results showed that Fixar® Viva Dry 0.05% was effective in preventing the toxic effects of aflatoxin that may be present in poultry diets.

2010 ◽  
Vol 89 (10) ◽  
pp. 2147-2156 ◽  
Author(s):  
J. Zhao ◽  
R.B. Shirley ◽  
J.D. Dibner ◽  
F. Uraizee ◽  
M. Officer ◽  
...  

Author(s):  
Omer Naseer ◽  
Jawaria Khan ◽  
Muhammad Khan ◽  
Muhammad Omer ◽  
Muhammad Avais ◽  
...  

The objective of this study was to determine the response of bovine calves against aflatoxin B1 (AFB1) in terms of feed consumption, hematological and serum biochemical parameters and to compare the efficacy of two different mycotoxin adsorbents, in vitro and in vivo. 36 bovine calves were divided into 4 groups. Group A was fed AFB1 added feed with the addition of â-glucans and Mannan oligosaccharides (Yeast Cell Wall), group B was fed AFB1 with hydrated sodium calcium aluminosilicate (HSCAS) and group C was fed AFB1 contaminated feed without addition of mycotoxin binders while group D was kept as negative control. AFB1 was given by gelatinized capsules at a dose rate of 1.0mg/ kg/ animal/ day. Results revealed average daily feed intake (ADFI) of AFB1 treated bovine calves significantly reduced (P less than 0.05) and all hematological parameters i.e; TEC, HGB, TLC, lymphocytes, neutrophils and monocytes, MCHC, HCT and MCH decreased significantly (P less than 0.05). Moreover, serum levels of AST, ALT, Creatinine and BUN were significantly increased (P less than 0.05) in response to AFB1. When compared between groups, YCW significantly (P less than 0.05) improved the feed consumption of bovine calves while HSCAS significantly reduced (P less than 0.05) the AFB1 induced deleterious alterations in hematology and serum biochemistry.


Toxins ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 24
Author(s):  
Alexandros Yiannikouris ◽  
Juha Apajalahti ◽  
Hannele Kettunen ◽  
Suvi Ojanperä ◽  
Andrew N. W. Bell ◽  
...  

In this work, adsorption of the carcinogenic mycotoxin aflatoxin B1 (AFB1) by two sequestrants—a yeast cell wall-based adsorbent (YCW) and a hydrated sodium calcium aluminosilicate (HSCAS)—was studied across four laboratory models: (1) an in vitro model from a reference method was employed to quantify the sorption capabilities of both sequestrants under buffer conditions at two pH values using liquid chromatography with fluorescence detection (LC-FLD); (2) in a second in vitro model, the influence of the upper gastrointestinal environment on the mycotoxin sorption capacity of the same two sequestrants was studied using a chronic AFB1 level commonly encountered in the field (10 µg/L and in the presence of feed); (3) the third model used a novel ex vivo approach to measure the absorption of 3H-labelled AFB1 in the intestinal tissue and the ability of the sequestrants to offset this process; and (4) a second previously developed ex vivo model readapted to AFB1 was used to measure the transfer of 3H-labelled AFB1 through live intestinal tissue, and the influence of sequestrants on its bioavailability by means of an Ussing chamber system. Despite some sorption effects caused by the feed itself studied in the second model, both in vitro models established that the adsorption capacity of both YCW and HSCAS is promoted at a low acidic pH. Ex vivo Models 3 and 4 showed that the same tested material formed a protective barrier on the epithelial mucosa and that they significantly reduced the transfer of AFB1 through live intestinal tissue. The results indicate that, by reducing the transmembrane transfer rate and reducing over 60% of the concentration of free AFB1, both products are able to significantly limit the bioavailability of AFB1. Moreover, there were limited differences between YCW and HSCAS in their sorption capacities. The inclusion of YCW in the dietary ration could have a positive influence in reducing AFB1′s physiological bioavailability.


2021 ◽  
Vol 8 ◽  
Author(s):  
Juan Omar Hernández-Ramírez ◽  
Rubén Merino-Guzmán ◽  
Guillermo Téllez-Isaías ◽  
Alma Vázquez-Durán ◽  
Abraham Méndez-Albores

In vivo experiments were conducted to evaluate the effectiveness of a yeast cell wall fraction (YCW) to reduce the negative impact of aflatoxin B1 (AFB1) to the intestinal epithelium in broiler chickens. Zeta potential (ζ-potential), point of zero charge (pHpzc), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) techniques were used to characterize the YCW. Two hundred one-day-old male Ross 308 broiler chickens were randomly allocated into four treatments: (1) control, chickens fed an AFB1-free diet; (2) AF, chickens feed an AFB1-contaminated diet (500 ng AFB1/g); (3) YCW, chickens fed an AFB1-free diet + 0.05% YCW; and (4) AF + YCW, chickens fed an AFB1-contaminated diet (500 ng AFB1/g) + 0.05% YCW. At the end of the 21-day feeding period, fluorescein isothiocyanate dextran (FITC-d) was administered to chicks by oral gavage to evaluate gastrointestinal leakage. Blood and duodenum samples were collected to assess serum biochemistry and histomorphology, respectively. Compared to the control group, chicks of the AF group significantly diminished weight gain (WG) and average daily feed intake (ADFI), and increased feed conversion ratio (FCR), mortality rate (MR), and intestinal lesion scores (p < 0.05). Alterations in some serum biochemical parameters, and damage to the intestinal integrity were also evident in the AF-intoxicated birds. YCW supplementation improved WG and FCR and increased villus height, villus area, crypt depth, and the number of goblet cells in villi. The effects of YCW on growth performance were not significant in chicks of the AF + YCW group; however, the treatment decreased MR and significantly ameliorated some biochemical and histomorphological alterations. The beneficial effect of YCW was more evident in promoting gut health since chickens of the AF + YCW group presented a significant reduction in serum FITC-d concentration. This positive effect was mainly related to the changes in negative charges of YCW due to changes in pH, the net negative surface charge above the pHpzc, the higher quantities of negative charged functional groups on the YCW surface, and its ability to form large aggregates. From these results, it can be concluded that YCW at low supplementation level can partially protect broilers' intestinal health from chronic exposure to AFB1.


2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 35-35
Author(s):  
Dailis Delazeri ◽  
Heloísa Bertagnon ◽  
Melina A Bonato ◽  
Liliana L Borges

Abstract The use of feed additives based on yeast cell wall has already been studied to favor the growth of beneficial intestinal bacteria to the detriment of pathogenic bacteria in ruminants. This fact reduces diarrhea, increases animal performance, and could promote lesser contamination of the bovine carcass at the time of slaughter, during the evisceration. The present study aims to verify if the yeast cell wall of Saccharomyces cerevisiae autolyzed yeast (AY) reduces total coliforms and Escherichia coli in feces and bovine carcass. Therefore, 36 steers, ½ Angus blood, finished in a feedlot, were submitted to three daily treatments for 105 days: control (diet without yeast), AY 4g (4g/animal/day, 2 x 1010cel/g of a commercial product based on Saccharomyces cerevisiae RumenYeast®), AY 7g (7g/animal/day, RumenYeast®). On days 29 and 90, after beginning in the feedlot, samples of feces were collected for E. coli and total coliforms identifications and counting. On the day of slaughter, 4 points of the carcasses were collected to identify and quantify E. coli, total fecal coliforms, and mesophiles by a petrifilm methodology. There was a reduction in E. coli and total coliforms for the AY 7g in the fecal samples comparing to the other groups (P = 0.0008 and 0.008, respectively), and a trend to reduce E. coli, total coliforms and mesophilic aerobes in the bovine carcass in AY 4g and AY 7g, comparing to the control group (P = 0.06; 0.10, and 0.05, respectively). It was concluded that supplementation with autolyzed yeast, especially when utilized in higher doses (7g), reduced fecal excretion and, consequently, reduce the carcass contamination by E. coli, mesophiles, and, total coliforms in animals during the feedlot period.


Toxins ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 597
Author(s):  
Jinzhu Yang ◽  
Tiantian Wang ◽  
Gang Lin ◽  
Mingzhu Li ◽  
Ronghua Zhu ◽  
...  

This study aimed to investigate the effects of dietary AFB1 on growth performance, health, intestinal microbiota communities and AFB1 tissue residues of turbot and evaluate the mitigation efficacy of yeast cell wall extract, Mycosorb® (YCWE) toward AFB1 contaminated dietary treatments. Nine experimental diets were formulated: Diet 1 (control): AFB1 free; Diets 2–5 or Diets 6–9: 20 μg AFB1/kg diet or 500 μg AFB1/kg diet + 0%, 0.1%, 0.2%, or 0.4% YCWE, respectively). The results showed that Diet 6 significantly decreased the concentrations of TP, GLB, C3, C4, T-CHO, TG but increased the activities of AST, ALT in serum, decreased the expressions of CAT, SOD, GPx, CYP1A but increased the expressions of CYP3A, GST-ζ1, p53 in liver. Diet 6 increased the AFB1 residues in serum and muscle, altered the intestinal microbiota composition, decreased the bacterial community diversity and the abundance of some potential probiotics. However, Diet 8 and Diet 9 restored the immune response, relieved adverse effects in liver, lowered the AFB1 residues in turbot tissues, promoted intestinal microbiota diversity and lowered the abundance of potentially pathogens. In conclusion, YCWE supplementation decreased the health effects of AFB1 on turbot, restoring biomarkers closer to the mycotoxin-free control diet.


Author(s):  
Giulia Maria Pires dos Santos ◽  
Gustavo Ramalho Cardoso dos Santos ◽  
Mariana Ingrid Dutra da Silva Xisto ◽  
Rodrigo Rollin-Pinheiro ◽  
Andréa Regina de Souza Baptista ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document